Peking University BOYA Distinguished Professor of Economics, Dean of Peking University Institute for Global Health and Development, and a fellow of the Chinese Academy of Medicine
Current Academic Positions
◼Peking University BOYA Distinguished Professor of Economics
◼Fellow, the Chinese Academy of Medicine
◼Dean, Peking University Institute for Global Health and Development
◼Founding Director, Peking University China Center for Health Economic Research
◼Chair of Academic Committee, Peking University Institute of Educational Economics
Leadership and Editorial Boards
◼Co-Organizer, The “US-China Track II Dialogue on Health” (2017 – present)
◼Member, The China State Council Health Reform Advisory Commission (2011 – present)
◼Chair, Economics Expert Panel for HTA, the National Healthcare Security Administration (2020-2022)
◼Editor-in-Chief, China Journal of Pharmaceutical Economics (2006 – present)
◼Associate Editor, Health Economics (2013 – present)
◼Associate Editor, Value in Health (2001-2012)
◼Co-Editor, China Economic Quarterly (2013-2017)
◼President, The Chinese Economists Society (2004-2005)
◼President, The ISPOR Asian Pacific Contortion (2004-2006)
Professional Honors
◼2025, The 19th China Pharmaceutical Development Award: Special Contribution Award
◼2025, China’s Top 10 Most Influential Economists
Education and Past Academic Positions
◼PhD. in economics, under supervision of Michael Grossman, City University of New York (1991)
◼Post-Doctoral Fellow, under supervision of William Hsiao, Harvard University (1992-1994)
◼Assistant Professor, University of Southern California (1994-2000)
◼Associate Professor (with tenure), University of North Carolina – Chapel Hill (2000-2006)
◼Full Professor, Peking University Guanghua School of Management (2006-2014)
Current Projects and Publication Profiles
◼Planetary Health Axis System (PHAS), an AI Dynamic Model System to Track the Human Footprints and Planetary Boundaries (2023 – present)
◼Survey of Medical Assessment for Robotic Technology (SMART), a nationally multicentered economic panel study on robotic surgeries compared to conventional approaches (2023 – present)
◼Book, The China Guidelines for Pharmacoeconomic Evaluations 2025 (3rd edition), Gordon G Liu and Wu Jing, 2026
◼Book, China's Healthcare System and Reform, Cambridge University Press, 2017, by Robert Burns (Wharton School) and Gordon G Liu (Peking University)
◼Commissioner, Jamison T Dean, Summers, H Larry et al., “Global health 2050: the path to halving premature death by mid-century,” The Lancet, 2024
◼Over 220 peer-reviewed publications, mostly in international SCI/SSCI journals, and some in Chinese journals